Cross-national epidemiology of DSM-IV major depressive episode
Stony Brook University · State University of New York · +22 more institutions
Abstract
Major depression is one of the leading causes of disability worldwide, yet epidemiologic data are not available for many countries, particularly low- to middle-income countries. In this paper, we present data on the prevalence, impairment and demographic correlates of depression from 18 high and low- to middle-income countries in the World Mental Health Survey Initiative.
Major depressive episodes (MDE) as defined by the Diagnostic and Statistical Manual of Mental Disorders, fourth edition (DMS-IV) were evaluated in face-to-face interviews using the World Health Organization Composite International Diagnostic Interview (CIDI). Data from 18 countries were analyzed in this report (n = 89,037). All countries surveyed representative, population-based samples of adults.
Citation impact
- FWCI
- 110.34
- Percentile
- 100%
- References
- 38
Authors
22- EJEvelyn J. BrometCorresponding
Stony Brook University, State University of New York
- LHLaura Helena Andrade
Universidade de São Paulo
- IHIrving Hwang
Harvard University
- NANancy A. Sampson
Harvard University
- JAJordi Alonso
Hospital Del Mar, Municipal Institute for Medical Research, Centro de Investigación Biomédica en Red de Epidemiología y Salud Pública
Topics & keywords
- CIDI
- Medicine
- Major depressive episode
- Mental health
- Public health
- Depression (economics)
- Epidemiology
- Population
- No poverty
Funding
- RWRobert Wood Johnson FoundationAwards: 044708, Grant 044708
- JDJohn D. and Catherine T. MacArthur FoundationAwards: R01 DA016558, R13-MH066849
- BSBristol-Myers Squibb
- ELEli Lilly and Company
- PPfizer
- GGlaxoSmithKline
- SSanofi
- WHWorld Health Organization
- SISRA International
- KPKaiser Permanente
- UOUniversity of Michigan
- JSJanssen Scientific Affairs
- ECEuropean CommissionAwards: QLG5-1999-01042, 2004123, SANCO 2004123
- FDFundação de Amparo à Pesquisa do Estado de São PauloAwards: 03/00204-3, 03/00204-
- GDGeneralitat de CatalunyaAward: 01042
- NINational Insurance Institute of Israel
- MOMinistry of Health, Labour and Welfare
- MDMinisterio de Ciencia y TecnologíaAward: SAF 2000-158-CE
- RPRegione PiemonteAward: 00/0028
- SASubstance Abuse and Mental Health Services Administration
- PFPfizer FoundationAwards: R01-MH069864, R01 DA016558, R13-MH066849, R03-TW006481
- PAPan American Health Organization
- IDInstituto de Salud Carlos IIIAwards: CB06/02/0046, CIBER CB06/02/0046, RETICS RD06/0011 REM-TAP, RETICS RD06/0011, RD06/0011, FIS 00/0028, CIBER CB06/02/0046
- DDDepartament de Salut, Generalitat de Catalunya
- NINational Institute of Mental HealthAwards: U01-MH60220, R01-MH069864, MH60220, R13-MH066849, R01MH070884
- NINational Institute on Drug AbuseAward: R01 DA016558
- FIFogarty International CenterAwards: R03-TW006481, FIRCA R03-TW006481
- CCilag